99 related articles for article (PubMed ID: 12616526)
21. A purine analog-sensitive protein kinase activity associates with Trk nerve growth factor receptors.
Volonté C; Loeb DM; Greene LA
J Neurochem; 1993 Aug; 61(2):664-72. PubMed ID: 7687657
[TBL] [Abstract][Full Text] [Related]
22. The role of tropomyosin-related kinase receptors in neurotrophin-induced rapid eye movement sleep in the cat.
Yamuy J; Ramos O; Torterolo P; Sampogna S; Chase MH
Neuroscience; 2005; 135(2):357-69. PubMed ID: 16125858
[TBL] [Abstract][Full Text] [Related]
23. Heparanase, TrkC and p75NTR: their functional involvement in human medulloblastoma cell invasion.
Sinnappah-Kang ND; Kaiser AJ; Blust BE; Mrak RE; Marchetti D
Int J Oncol; 2005 Sep; 27(3):617-26. PubMed ID: 16077909
[TBL] [Abstract][Full Text] [Related]
24. Inverse expression of neurotrophins and neurotrophin receptors at the invasion front of human-melanoma brain metastases.
Marchetti D; McCutcheon I; Ross M; Nicolson G
Int J Oncol; 1995 Jul; 7(1):87-94. PubMed ID: 21552811
[TBL] [Abstract][Full Text] [Related]
25. p75 neurotrophin receptor mediates neurotrophin activation of NF-kappa B and induction of iNOS expression in P19 neurons.
Burke MA; Bothwell M
J Neurobiol; 2003 May; 55(2):191-203. PubMed ID: 12672017
[TBL] [Abstract][Full Text] [Related]
26. Co-expression of the P75 neurotrophin receptor and neurotrophin receptor-interacting melanoma antigen homolog in the mature rat brain.
Barrett GL; Greferath U; Barker PA; Trieu J; Bennie A
Neuroscience; 2005; 133(2):381-92. PubMed ID: 15878242
[TBL] [Abstract][Full Text] [Related]
27. Crystal structure of the neurotrophin-3 and p75NTR symmetrical complex.
Gong Y; Cao P; Yu HJ; Jiang T
Nature; 2008 Aug; 454(7205):789-93. PubMed ID: 18596692
[TBL] [Abstract][Full Text] [Related]
28. Neurotrophin-3 signaling in mammalian Merkel cell development.
Szeder V; Grim M; Kucera J; Sieber-Blum M
Dev Dyn; 2003 Dec; 228(4):623-9. PubMed ID: 14648839
[TBL] [Abstract][Full Text] [Related]
29. Deafferentation and neurotrophin-mediated intraspinal sprouting: a central role for the p75 neurotrophin receptor.
Scott AL; Borisoff JF; Ramer MS
Eur J Neurosci; 2005 Jan; 21(1):81-92. PubMed ID: 15654845
[TBL] [Abstract][Full Text] [Related]
30. Association of a purine-analogue-sensitive protein kinase activity with p75 nerve growth factor receptors.
Volonté C; Ross AH; Greene LA
Mol Biol Cell; 1993 Jan; 4(1):71-8. PubMed ID: 7680248
[TBL] [Abstract][Full Text] [Related]
31. Structure of nerve growth factor complexed with the shared neurotrophin receptor p75.
He XL; Garcia KC
Science; 2004 May; 304(5672):870-5. PubMed ID: 15131306
[TBL] [Abstract][Full Text] [Related]
32. Tyrosine kinase inhibitor CEP-701 blocks the NTRK1/NGF receptor and limits the invasive capability of prostate cancer cells in vitro.
Festuccia C; Muzi P; Gravina GL; Millimaggi D; Speca S; Dolo V; Ricevuto E; Vicentini C; Bologna M
Int J Oncol; 2007 Jan; 30(1):193-200. PubMed ID: 17143529
[TBL] [Abstract][Full Text] [Related]
33. Nerve growth factor regulates substance P in adult sensory neurons through both TrkA and p75 receptors.
Skoff AM; Adler JE
Exp Neurol; 2006 Feb; 197(2):430-6. PubMed ID: 16300761
[TBL] [Abstract][Full Text] [Related]
34. Effect of exogenous neurotrophins on Trk receptor phosphorylation, cell proliferation, and neurotrophin secretion by cells isolated from the human lamina cribrosa.
Lambert WS; Clark AF; Wordinger RJ
Mol Vis; 2004 Apr; 10():289-96. PubMed ID: 15105791
[TBL] [Abstract][Full Text] [Related]
35. In vitro and in vivo effects of bicalutamide on the expression of TrkA and P75 neurotrophin receptors in prostate carcinoma.
Festuccia C; Gravina GL; Muzi P; Pomante R; Ventura L; Ricevuto E; Vicentini C; Bologna M
Prostate; 2007 Sep; 67(12):1255-64. PubMed ID: 17596848
[TBL] [Abstract][Full Text] [Related]
36. Differential activity of the nerve growth factor (NGF) antagonist PD90780 [7-(benzolylamino)-4,9-dihydro-4-methyl-9-oxo-pyrazolo[5,1-b]quinazoline-2-carboxylic acid] suggests altered NGF-p75NTR interactions in the presence of TrkA.
Colquhoun A; Lawrance GM; Shamovsky IL; Riopelle RJ; Ross GM
J Pharmacol Exp Ther; 2004 Aug; 310(2):505-11. PubMed ID: 15051797
[TBL] [Abstract][Full Text] [Related]
37. Neurotrophin receptor expression in human primary retinoblastomas and retinoblastoma cell lines.
Stephan H; Zakrzewski JL; Bölöni R; Grasemann C; Lohmann DR; Eggert A
Pediatr Blood Cancer; 2008 Feb; 50(2):218-22. PubMed ID: 17973327
[TBL] [Abstract][Full Text] [Related]
38. Expression and cellular distribution of high- and low-affinity neurotrophin receptors in malformations of cortical development.
Aronica E; Ozbas-Gerçeker F; Redeker S; Ramkema M; Spliet WG; van Rijen PC; Leenstra S; Gorter JA; Troost D
Acta Neuropathol; 2004 Nov; 108(5):422-34. PubMed ID: 15375667
[TBL] [Abstract][Full Text] [Related]
39. Promoting neurotrophic effects by GPCR ligands.
Jeanneteau F; Chao MV
Novartis Found Symp; 2006; 276():181-9; discussion 189-92, 233-7, 275-81. PubMed ID: 16805430
[TBL] [Abstract][Full Text] [Related]
40. Distinct effects of p75 in mediating actions of neurotrophins on basal forebrain oligodendrocytes.
Du Y; Fischer TZ; Clinton-Luke P; Lercher LD; Dreyfus CF
Mol Cell Neurosci; 2006 Feb; 31(2):366-75. PubMed ID: 16356734
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
